
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| IPS(L) | 986 | 58.9% | -7.36 | 6 | 17.6% |
| CentralBrain-unspecified | 331 | 19.8% | -3.67 | 26 | 76.5% |
| SPS(L) | 353 | 21.1% | -7.46 | 2 | 5.9% |
| GNG | 3 | 0.2% | -inf | 0 | 0.0% |
| SMP(L) | 1 | 0.1% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns OCC02a | % In | CV |
|---|---|---|---|---|---|
| PS053 (L) | 1 | ACh | 137.3 | 25.8% | 0.0 |
| CB4228 (R) | 4 | ACh | 40.3 | 7.6% | 0.4 |
| PS196_b (R) | 1 | ACh | 33.3 | 6.3% | 0.0 |
| VS (L) | 3 | ACh | 28.3 | 5.3% | 0.7 |
| WED033 (L) | 5 | GABA | 25.7 | 4.8% | 0.6 |
| AN04B023 (L) | 2 | ACh | 22.7 | 4.3% | 0.4 |
| LAL026_b (L) | 1 | ACh | 20 | 3.8% | 0.0 |
| LAL026_a (L) | 1 | ACh | 17 | 3.2% | 0.0 |
| AN04B003 (L) | 3 | ACh | 16.7 | 3.1% | 1.3 |
| PS331 (L) | 3 | GABA | 16 | 3.0% | 0.4 |
| CB2050 (R) | 2 | ACh | 14.7 | 2.8% | 0.2 |
| HSN (L) | 1 | ACh | 11.3 | 2.1% | 0.0 |
| MeVP9 (L) | 5 | ACh | 11.3 | 2.1% | 0.7 |
| PS059 (L) | 2 | GABA | 11.3 | 2.1% | 0.1 |
| VSm (L) | 2 | ACh | 11 | 2.1% | 0.2 |
| PS324 (R) | 2 | GABA | 9.3 | 1.8% | 0.1 |
| DNg51 (R) | 2 | ACh | 9.3 | 1.8% | 0.3 |
| PS324 (L) | 2 | GABA | 9 | 1.7% | 0.0 |
| LAL029_e (L) | 1 | ACh | 6.7 | 1.3% | 0.0 |
| PS093 (L) | 1 | GABA | 6 | 1.1% | 0.0 |
| MeVP8 (L) | 5 | ACh | 6 | 1.1% | 0.6 |
| PS331 (R) | 2 | GABA | 5 | 0.9% | 0.3 |
| GNG435 (R) | 1 | Glu | 4 | 0.8% | 0.0 |
| PS091 (L) | 1 | GABA | 3.3 | 0.6% | 0.0 |
| OA-AL2i4 (L) | 1 | OA | 3.3 | 0.6% | 0.0 |
| LAL096 (R) | 3 | Glu | 3.3 | 0.6% | 0.3 |
| LAL133_e (L) | 1 | Glu | 2.7 | 0.5% | 0.0 |
| MeVP59 (L) | 1 | ACh | 2.7 | 0.5% | 0.0 |
| IB116 (L) | 1 | GABA | 2.3 | 0.4% | 0.0 |
| OA-VUMa1 (M) | 2 | OA | 2.3 | 0.4% | 0.1 |
| MeVP6 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| GNG413 (R) | 2 | Glu | 2 | 0.4% | 0.7 |
| MeVPMe5 (R) | 4 | Glu | 2 | 0.4% | 0.6 |
| CB4094 (R) | 3 | ACh | 1.7 | 0.3% | 0.6 |
| CB3865 (R) | 3 | Glu | 1.7 | 0.3% | 0.6 |
| PS313 (L) | 1 | ACh | 1.7 | 0.3% | 0.0 |
| MeVPMe1 (L) | 2 | Glu | 1.7 | 0.3% | 0.6 |
| DNp18 (L) | 1 | ACh | 1.3 | 0.3% | 0.0 |
| GNG428 (R) | 1 | Glu | 1.3 | 0.3% | 0.0 |
| OCC02a (L) | 3 | unc | 1.3 | 0.3% | 0.4 |
| PS334 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| SAD034 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| DNp28 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| OCG03 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PS051 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LT82b (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| HSE (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| AN07B069_b (R) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| PS229 (R) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| MeVPLp2 (R) | 1 | Glu | 0.7 | 0.1% | 0.0 |
| LoVC22 (R) | 1 | DA | 0.7 | 0.1% | 0.0 |
| DNg36_b (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| PS282 (L) | 2 | Glu | 0.7 | 0.1% | 0.0 |
| PS072 (L) | 1 | GABA | 0.7 | 0.1% | 0.0 |
| DNge115 (R) | 2 | ACh | 0.7 | 0.1% | 0.0 |
| PS126 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| GNG494 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| PS077 (L) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| DNg36_a (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| OCG03 (R) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| PS262 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| PS213 (L) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| PS321 (R) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| OA-VUMa4 (M) | 1 | OA | 0.3 | 0.1% | 0.0 |
| GNG701m (L) | 1 | unc | 0.3 | 0.1% | 0.0 |
| DNp73 (R) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| MeVPMe2 (R) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| PS279 (L) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| PLP131 (L) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| CB2294 (R) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| CB1464 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| PS118 (L) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| PS334 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| DNge006 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| MeVC7b (R) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| LoVC18 (L) | 1 | DA | 0.3 | 0.1% | 0.0 |
| LPT50 (R) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| HSS (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| MeVPLp1 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| H2 (R) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| OCC02b (L) | 1 | unc | 0.3 | 0.1% | 0.0 |
| CB2205 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| CB0266 (R) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| PS224 (R) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| PS141 (L) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| CB1421 (L) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| PS356 (L) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| MeVP56 (L) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| SAD013 (R) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| DNae002 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| DNp19 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| downstream partner | # | NT | conns OCC02a | % Out | CV |
|---|---|---|---|---|---|
| OCC02b (L) | 2 | unc | 1.3 | 14.8% | 0.5 |
| OCC02a (L) | 3 | unc | 1.3 | 14.8% | 0.4 |
| CL246 (L) | 1 | GABA | 1 | 11.1% | 0.0 |
| GNG307 (L) | 1 | ACh | 0.7 | 7.4% | 0.0 |
| PS059 (L) | 1 | GABA | 0.3 | 3.7% | 0.0 |
| OCG01a (L) | 1 | Glu | 0.3 | 3.7% | 0.0 |
| PS313 (L) | 1 | ACh | 0.3 | 3.7% | 0.0 |
| DNae002 (L) | 1 | ACh | 0.3 | 3.7% | 0.0 |
| MeVPLp1 (L) | 1 | ACh | 0.3 | 3.7% | 0.0 |
| PS061 (R) | 1 | ACh | 0.3 | 3.7% | 0.0 |
| CB2050 (R) | 1 | ACh | 0.3 | 3.7% | 0.0 |
| PS072 (L) | 1 | GABA | 0.3 | 3.7% | 0.0 |
| DNpe012_a (L) | 1 | ACh | 0.3 | 3.7% | 0.0 |
| PS159 (L) | 1 | ACh | 0.3 | 3.7% | 0.0 |
| GNG276 (L) | 1 | unc | 0.3 | 3.7% | 0.0 |
| OLVC3 (L) | 1 | ACh | 0.3 | 3.7% | 0.0 |
| DNp19 (L) | 1 | ACh | 0.3 | 3.7% | 0.0 |
| MeVC11 (R) | 1 | ACh | 0.3 | 3.7% | 0.0 |